Locations:
Search IconSearch

News & Insight

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight

Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight

Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

prostate cancer

Lutetium-PSMA for Metastatic Prostate Cancer (Podcast)

FDA-approved therapy offers promise for patients with castrate-resistant prostate cancer

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Abraham, MD
July 20, 2022/Cancer/News & Insight

Building Trust is a Matter of Life and Death

The cornerstone of a successful doctor-patient relationship

Magnetic resonance imaging (MRI) of the brain, brain tumor
October 28, 2021/Cancer/News & Insight

Cognitive Function Remains Stable Following Concurrent Temozolomide-based Chemoradiation Therapy in Low-Grade Gliomas

Study shows encouraging safety results in rare type of adult brain cancer

Brian Bolwell, MD
January 25, 2021/Cancer/News & Insight

The Cancer Center and Cleveland Clinic’s Centennial

Reflecting on our progress and potential

T-cells_650x450
January 21, 2021/Cancer/News & Insight

Managing CAR T-Cell Therapy Across Cancer Center Programs

Researching and operationalizing a new therapy

Covid-19 vaccine
January 19, 2021/Cancer/News & Insight

COVID-19 mRNA Vaccines: What Does This Mean for Cancer?

Insights from the Director of the Center for Immunotherapy and Precision Immuno-Oncology

BackPage 6 of 10Next

Advertisement

Ad